Company Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally.
The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.
It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.
Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Country | United States |
Founded | 1986 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 459 |
CEO | Paul Josephs |
Contact Details
Address: 3515 Lyman Boulevard Chaska, Minnesota 55318 United States | |
Phone | (952) 368-4300 |
Website | lifecore.com |
Stock Details
Ticker Symbol | LFCR |
Exchange | NASDAQ |
Fiscal Year | June - May |
Reporting Currency | USD |
CIK Code | 0001005286 |
ISIN Number | US5147661046 |
Employer ID | 94-3025618 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
James G. Hall | Chief Executive Officer, President and Director |
John D. Morberg | Executive Vice President and Chief Financial Officer |
Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. |
Steve W. Laninga | Vice President of Operations |
Dr. Kipling Thacker Ph.D. | Vice President and Chief Scientist |
Aaron Perlitsh | Director of Internal Audit and Chief Compliance Officer |
Darren M. Hieber | Senior Vice President of Corporate Development and Partnerships |
Kara Morley | Senior Vice President of Human Resources |
Jackie Q. Klecker | Executive Vice President and GM |
Matt Augustson | Senior Vice President of Information Technology |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 19, 2024 | DEF 14A | Other definitive proxy statements |
Jul 12, 2024 | 8-K | Current Report |
Jul 8, 2024 | PRE 14A | Other preliminary proxy statements |
Jul 5, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jul 1, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jul 1, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jul 1, 2024 | 8-K | Current Report |
Jun 13, 2024 | UPLOAD | Filing |
Jun 11, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jun 7, 2024 | 8-K | Current Report |